Cargando…
Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787611/ https://www.ncbi.nlm.nih.gov/pubmed/35044238 http://dx.doi.org/10.2217/fmb-2021-0277 |
| _version_ | 1784639394834022400 |
|---|---|
| author | Frank, Michael |
| author_facet | Frank, Michael |
| author_sort | Frank, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8787611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Future Medicine Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87876112022-02-14 Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank Frank, Michael Future Microbiol Interview Future Medicine Ltd 2022-01-19 2022-01 /pmc/articles/PMC8787611/ /pubmed/35044238 http://dx.doi.org/10.2217/fmb-2021-0277 Text en © 2022 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Interview Frank, Michael Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
| title | Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
| title_full | Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
| title_fullStr | Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
| title_full_unstemmed | Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
| title_short | Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
| title_sort | bucillamine in the treatment of patients with mild to moderate covid-19: an interview with michael frank |
| topic | Interview |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787611/ https://www.ncbi.nlm.nih.gov/pubmed/35044238 http://dx.doi.org/10.2217/fmb-2021-0277 |
| work_keys_str_mv | AT frankmichael bucillamineinthetreatmentofpatientswithmildtomoderatecovid19aninterviewwithmichaelfrank |